$4.27
+0.08 (+1.79%)
Open$4.14
Previous Close$4.20
Day High$4.48
Day Low$4.13
52W High$141.50
52W Low$3.29
Volume—
Avg Volume27.1K
Market Cap5.61M
P/E Ratio—
EPS$-27.15
SectorBiotechnology
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 7.61M | 6.76M | 8.11M |
| Net Income | 881.2K | 841.9K | 1.08M |
| Profit Margin | 11.6% | 12.5% | 13.3% |
| EBITDA | 1.17M | 1.13M | 1.25M |
| Free Cash Flow | 539.3K | 438.1K | 671.3K |
| Rev Growth | -2.4% | +10.1% | +12.1% |
| Debt/Equity | 0.23 | 0.23 | 0.19 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $266.28 | +0.73% | 74.3 | 468.50B |
| AMGN | Amgen Inc | $418.13 | +0.85% | 25.1 | 219.78B |
| GILD | Gilead Sciences Inc | $152.21 | +0.85% | — | 185.02B |
| VRTX | Vertex Pharmaceuticals Inc | $527.67 | +0.28% | 30.5 | 134.17B |
| REGN | Regeneron Pharmaceuticals | $752.25 | -4.54% | 18.8 | 81.31B |
| ALNY | Alnylam Pharmaceuticals Inc | $255.36 | -0.23% | 41.4 | 33.44B |